» Articles » PMID: 24211863

Evaluation of a Thermosensitive Atelocollagen Punctal Plug Treatment for Dry Eye Disease

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 2013 Nov 12
PMID 24211863
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the efficacy of a thermosensitive atelocollagen punctal plug in the treatment of dry eye disease.

Design: Prospective observational case series.

Methods: The thermosensitive atelocollagen punctal plug was warmed at 37 C, 39 C, 41 C, and 43 C to evaluate the appropriate temperature and time for solidification. Dry eye patients were divided into 2 groups according to the preparation method of the atelocollagen punctal plug. In the conventional implantation group, atelocollagen gel was kept at room temperature for 15 minutes before implantation (27 eyes of 14 patients). In the preheating group, atelocollagen was warmed at 41 C for 8 minutes before implantation (23 eyes of 13 dry eye patients). Strip meniscometry, vital stainings, tear film break-up time (BUT), and symptom scores were evaluated before and 1 month after plug implantation.

Results: In vitro experiments revealed that heating at 41 C for 8 minutes was sufficient to solidify the gel. The mean fluorescein score in the conventional implantation group significantly improved after treatment (before, 3.5 ± 2.3 points; after, 2.5 ± 0.9 points, P < .05). In the preheating group, the mean fluorescein score (before, 3.7 ± 1.7 points; after, 1.5 ± 1.2 points), strip meniscometry (before, 0.6 ± 0.7 mm; after, 1.1 ± 0.3 mm), BUT (before, 3.2 ± 0.7 seconds; after, 4.8 ± 1.0 seconds), and visual analog scale scores (before, 6.6 ± 1.5 points; after, 4.1 ± 0.9 points) significantly improved after treatment (P < .05).

Conclusion: The thermosensitive atelocollagen punctal plug was effective for dry eye treatment. The preheating method was found to be useful to strengthen the efficacy of the thermosensitive atelocollagen punctal plug.

Citing Articles

Dry Eye Disease: An Update on Changing Perspectives on Causes, Diagnosis, and Management.

Dash N, Choudhury D Cureus. 2024; 16(5):e59985.

PMID: 38854318 PMC: 11162257. DOI: 10.7759/cureus.59985.


Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases.

Mostafa M, Al Fatease A, Alany R, Abdelkader H Pharmaceutics. 2023; 15(6).

PMID: 37376194 PMC: 10302848. DOI: 10.3390/pharmaceutics15061746.


Feasibility of Strip Meniscometry for Tear Volume Evaluation in Lacrimal Passage Obstruction.

Osawa I, Esaka Y, Kojima T, Simsek C, Kudo H, Dogru M Diagnostics (Basel). 2020; 10(4).

PMID: 32218304 PMC: 7235822. DOI: 10.3390/diagnostics10040179.


A New Perspective on Dry Eye Classification: Proposal by the Asia Dry Eye Society.

Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M Eye Contact Lens. 2019; 46 Suppl 1:S2-S13.

PMID: 31425351 PMC: 7423530. DOI: 10.1097/ICL.0000000000000643.


Punctal occlusion for dry eye syndrome.

Ervin A, Law A, Pucker A Cochrane Database Syst Rev. 2017; 6:CD006775.

PMID: 28649802 PMC: 5568656. DOI: 10.1002/14651858.CD006775.pub3.